|
ASAH2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.638900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.404360E-02 |
| Normal-vs-Stage2 |
2.090600E-01 |
| Normal-vs-Stage3 |
7.823100E-03 |
| Normal-vs-Stage4 |
1.84261999999213E-05 |
| Stage1-vs-Stage2 |
4.857200E-01 |
| Stage1-vs-Stage3 |
4.947800E-01 |
| Stage1-vs-Stage4 |
6.806900E-04 |
| Stage2-vs-Stage3 |
2.988800E-01 |
| Stage2-vs-Stage4 |
5.702400E-03 |
| Stage3-vs-Stage4 |
1.478280E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.703700E-03 |
| Normal-vs-AfricanAmerican |
7.005400E-01 |
| Normal-vs-Asian |
4.578800E-04 |
| Caucasian-vs-AfricanAmerican |
9.846200E-02 |
| Caucasian-vs-Asian |
8.568300E-02 |
| AfricanAmerican-vs-Asian |
3.529500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.011300E-04 |
| Normal-vs-Female |
8.321200E-03 |
| Male-vs-Female |
1.086400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.187500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.370400E-04 |
| Normal-vs-Age(61-80Yrs) |
7.007600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.640400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.178830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.945000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.003000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.326000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.713600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.872200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.298600E-01 |
| Classical-VS-Follicular |
2.734600E-01 |
| Classical-VS-Other |
2.960200E-03 |
| Classical-VS-Normal |
3.283500E-03 |
| Tall-VS-Follicular |
6.187800E-01 |
| Tall-VS-Other |
4.295900E-03 |
| Tall-VS-Normal |
7.776100E-02 |
| Follicular-VS-Other |
7.440800E-04 |
| Follicular-VS-Normal |
1.154010E-01 |
| Other-VS-Normal |
2.31519999999152E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.529900E-02 |
| Normal-vs-N1 |
2.830400E-04 |
| N0-vs-N1 |
1.396300E-02 |
|
|
